DRUG CHIRALITY - ON THE MECHANISM OF R-ARYL PROPIONIC-ACID CLASS NSAIDS - EPIMERIZATION IN HUMANS AND THE CLINICAL IMPLICATIONS FOR THE USEOF RACEMATES
Wj. Wechter, DRUG CHIRALITY - ON THE MECHANISM OF R-ARYL PROPIONIC-ACID CLASS NSAIDS - EPIMERIZATION IN HUMANS AND THE CLINICAL IMPLICATIONS FOR THE USEOF RACEMATES, Journal of clinical pharmacology, 34(11), 1994, pp. 1036-1042
This review summarizes and comments on the current understanding of bo
th the biochemical and clinical implications of the epimerization of R
-aryl propionic (APA) class (1) nonsteroidal anti-inflammatory agents
(NSAIDs) to S-enantiomers in humans. This article focuses principally
on rac-ibuprofen and its enantiomers. In the United States, five comme
rcialized NSAIDs are APAs. Only two of them, rac-ibuprofen and rac-fen
oprofen, are subject to significant epimerization in humans. The remai
ning three, rac-flurbiprofen, rac-ketoprofen, and S-naproxen, are not
of interest in this context.